Clinical applications of hormonal therapy in ovarian cancer

Gautam G. Rao, David S. Miller

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The ovary is an endocrine organ and an end organ. Hormones and their receptors have been associated with ovarian cancer and may be related to its causation. Some data suggest that hormonal therapies may have some effect on ovarian cancer in palliative settings. No hormonal therapy is approved by the US Food and Drug Administration (FDA) for the treatment of any type of ovarian malignancy nor is it listed as an active agent by any of the authoritative compendia. Because of the endocrine associations with ovarian cancer, the minimal side effects, and demonstrated activity of hormonal therapies in other endocrine-associated malignancies, further study is needed.

Original languageEnglish (US)
Pages (from-to)97-102
Number of pages6
JournalCurrent Treatment Options in Oncology
Volume6
Issue number2
StatePublished - Mar 2005

Fingerprint

Ovarian Neoplasms
United States Food and Drug Administration
Causality
Ovary
Neoplasms
Therapeutics
Hormones

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Clinical applications of hormonal therapy in ovarian cancer. / Rao, Gautam G.; Miller, David S.

In: Current Treatment Options in Oncology, Vol. 6, No. 2, 03.2005, p. 97-102.

Research output: Contribution to journalArticle

@article{339efac116c44920bcf2d72c6ed329f0,
title = "Clinical applications of hormonal therapy in ovarian cancer",
abstract = "The ovary is an endocrine organ and an end organ. Hormones and their receptors have been associated with ovarian cancer and may be related to its causation. Some data suggest that hormonal therapies may have some effect on ovarian cancer in palliative settings. No hormonal therapy is approved by the US Food and Drug Administration (FDA) for the treatment of any type of ovarian malignancy nor is it listed as an active agent by any of the authoritative compendia. Because of the endocrine associations with ovarian cancer, the minimal side effects, and demonstrated activity of hormonal therapies in other endocrine-associated malignancies, further study is needed.",
author = "Rao, {Gautam G.} and Miller, {David S.}",
year = "2005",
month = "3",
language = "English (US)",
volume = "6",
pages = "97--102",
journal = "Current Treatment Options in Oncology",
issn = "1527-2729",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Clinical applications of hormonal therapy in ovarian cancer

AU - Rao, Gautam G.

AU - Miller, David S.

PY - 2005/3

Y1 - 2005/3

N2 - The ovary is an endocrine organ and an end organ. Hormones and their receptors have been associated with ovarian cancer and may be related to its causation. Some data suggest that hormonal therapies may have some effect on ovarian cancer in palliative settings. No hormonal therapy is approved by the US Food and Drug Administration (FDA) for the treatment of any type of ovarian malignancy nor is it listed as an active agent by any of the authoritative compendia. Because of the endocrine associations with ovarian cancer, the minimal side effects, and demonstrated activity of hormonal therapies in other endocrine-associated malignancies, further study is needed.

AB - The ovary is an endocrine organ and an end organ. Hormones and their receptors have been associated with ovarian cancer and may be related to its causation. Some data suggest that hormonal therapies may have some effect on ovarian cancer in palliative settings. No hormonal therapy is approved by the US Food and Drug Administration (FDA) for the treatment of any type of ovarian malignancy nor is it listed as an active agent by any of the authoritative compendia. Because of the endocrine associations with ovarian cancer, the minimal side effects, and demonstrated activity of hormonal therapies in other endocrine-associated malignancies, further study is needed.

UR - http://www.scopus.com/inward/record.url?scp=15344343626&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=15344343626&partnerID=8YFLogxK

M3 - Article

C2 - 15717991

AN - SCOPUS:15344343626

VL - 6

SP - 97

EP - 102

JO - Current Treatment Options in Oncology

JF - Current Treatment Options in Oncology

SN - 1527-2729

IS - 2

ER -